TREA

97939283 - NETWORK MEDICINES

Follow

Information

  • Trademark
  • 97939283
  • Serial Number
    97939283
  • Filing Date
    May 16, 2023
    a year ago
  • Transaction Date
    July 05, 2024
    7 months ago
  • Status Date
    July 05, 2024
    7 months ago
  • Location Date
    March 21, 2024
    10 months ago
  • Status Code
    602
  • Current Location
    TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    TENG, SIMON
  • Attorney Docket Number
    V03252001000
    Attorney Name
    Christina M. Licursi
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
4
Mark Identification
NETWORK MEDICINES
Case File Statements
  • GS0051: Pharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation
  • GS0441: Regenerative medicine services
  • GS0421: Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals
Case File Event Statements
  • 11/30/2023 - a year ago
    2 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/15/2023 - a year ago
    1 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/30/2023 - a year ago
    3 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/30/2023 - a year ago
    4 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/30/2023 - a year ago
    5 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/26/2024 - 11 months ago
    8 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/26/2024 - 11 months ago
    7 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/26/2024 - 11 months ago
    6 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/21/2024 - 10 months ago
    9 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/21/2024 - 10 months ago
    10 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/21/2024 - 10 months ago
    11 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/2/2024 - 10 months ago
    14 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/2/2024 - 10 months ago
    13 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 4/2/2024 - 10 months ago
    12 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 7/5/2024 - 7 months ago
    15 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 7/5/2024 - 7 months ago
    16 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2